{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T07:26:28Z","timestamp":1787037988156,"version":"build-2736575974"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"DOI":"10.1007\/s11739-026-04484-x","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:53:21Z","timestamp":1787036001000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Breaking barriers: navigating cardiovascular health in the transgender community"],"prefix":"10.1007","author":[{"given":"Palak","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhairrya","family":"Diwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Naveya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Araj Naveed","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurneet","family":"Dhingra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kshitiz Raj","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anim","family":"Asif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanshika","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balihar","family":"Bajwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8622-0300","authenticated-orcid":false,"given":"Vikash Kumar","family":"Karmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"issue":"1","key":"4484_CR1","doi-asserted-by":"publisher","first-page":"ITC1","DOI":"10.7326\/AITC201907020","volume":"171","author":"JD Safer","year":"2019","unstructured":"Safer JD, Tangpricha V (2019) Care of the transgender patient. Ann Intern Med 171(1):ITC1-16. https:\/\/doi.org\/10.7326\/AITC201907020","journal-title":"Ann Intern Med"},{"key":"4484_CR2","unstructured":"The Health of Lesbian, Gay, Bisexual, and transgender people: building a foundation for better understanding - PubMed [Internet]. [cited 2026 Mar 30]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/22013611\/"},{"issue":"5","key":"4484_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1089\/trgh.2020.0188","volume":"7","author":"I Howerton","year":"2022","unstructured":"Howerton I, Harris JK (2022) Transgender identity and cardiovascular disease. Transgender Health 7(5):407\u2013415. https:\/\/doi.org\/10.1089\/trgh.2020.0188","journal-title":"Transgender Health"},{"issue":"3","key":"4484_CR4","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.amepre.2018.04.045","volume":"55","author":"JM Downing","year":"2018","unstructured":"Downing JM, Przedworski JM (2018) Health of transgender adults in the U.S., 2014\u20132016. Am J Prev Med 55(3):336\u2013344. https:\/\/doi.org\/10.1016\/j.amepre.2018.04.045","journal-title":"Am J Prev Med"},{"key":"4484_CR5","unstructured":"LGBTQ+ Health Disparities | Cigna Healthcare [Internet]. [cited 2026 Mar 30]. Available from: https:\/\/www.cigna.com\/knowledge-center\/lgbt-disparities"},{"issue":"2","key":"4484_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4081\/gh.2019.752","volume":"14","author":"WC Goedel","year":"2019","unstructured":"Goedel WC, Regan SD, Chaix B, Radix A, Reisner SL, Janssen AC et al (2019) Using global positioning system methods to explore mobility patterns and exposure to high HIV prevalence neighbourhoods among transgender women in New York. Geospat Health 14(2):10. https:\/\/doi.org\/10.4081\/gh.2019.752","journal-title":"Geospat Health"},{"issue":"1","key":"4484_CR7","doi-asserted-by":"publisher","DOI":"10.5334\/gh.1300","volume":"19","author":"JE Coss\u00edo Aranda","year":"2024","unstructured":"Coss\u00edo Aranda JE, Jain V, Figueiras-Graillet LM, Arias-Mendoza A, Cu\u00e9llar JL, Berni Betancourt A et al (2024) Toward a better understanding of cardiovascular risk in the transgender and gender-diverse community: a global call to action. Glob Heart 19(1):27. https:\/\/doi.org\/10.5334\/gh.1300","journal-title":"Glob Heart"},{"issue":"4","key":"4484_CR8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.119.005597","volume":"12","author":"T Alzahrani","year":"2019","unstructured":"Alzahrani T, Nguyen T, Ryan A, Dwairy A, McCaffrey J, Yunus R et al (2019) Cardiovascular disease risk factors and myocardial infarction in the transgender population. Circ: Cardiovasc Qual Outcomes 12(4):e005597. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.119.005597","journal-title":"Circ: Cardiovasc Qual Outcomes"},{"issue":"4","key":"4484_CR9","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.jsxm.2020.01.012","volume":"17","author":"G T\u2019Sjoen","year":"2020","unstructured":"T\u2019Sjoen G, Arcelus J, De Vries ALC, Fisher AD, Nieder TO, \u00d6zer M et al (2020) European society for sexual medicine position statement \u201cassessment and hormonal management in adolescent and adult trans people, with attention for sexual function and satisfaction.\u201d J Sex Med 17(4):570\u2013584. https:\/\/doi.org\/10.1016\/j.jsxm.2020.01.012","journal-title":"J Sex Med"},{"issue":"11","key":"4484_CR10","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1161\/CIRCULATIONAHA.118.038584","volume":"139","author":"NM Nota","year":"2019","unstructured":"Nota NM, Wiepjes CM, De Blok CJM, Gooren LJG, Kreukels BPC, Den Heijer M (2019) Occurrence of acute cardiovascular events in transgender individuals receiving hormone therapy: results from a large cohort study. Circ 139(11):1461\u20131462. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.038584","journal-title":"Circ"},{"issue":"12","key":"4484_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.718200","volume":"30","author":"G Aranda","year":"2021","unstructured":"Aranda G, Halperin I, Gomez-Gil E, Hanzu FA, Segu\u00ed N, Guillamon A et al (2021) Cardiovascular risk associated with gender affirming hormone therapy in transgender population. Front Endocrinol (Lausanne) 30(12):718200. https:\/\/doi.org\/10.3389\/fendo.2021.718200","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"4484_CR12","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1111\/jsm.12571","volume":"11","author":"K Wierckx","year":"2014","unstructured":"Wierckx K, Van Caenegem E, Schreiner T, Haraldsen I, Fisher AD, Toye K et al (2014) Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence. J Sex Med 11(8):1999\u20132011. https:\/\/doi.org\/10.1111\/jsm.12571","journal-title":"J Sex Med"},{"issue":"4","key":"4484_CR13","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1530\/EJE-10-1038","volume":"164","author":"H Asscheman","year":"2011","unstructured":"Asscheman H, Giltay EJ, Megens JAJ, de Ronde WP, van Trotsenburg MAA, Gooren LJG (2011) A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones. Eur J Endocrinol 164(4):635\u2013642. https:\/\/doi.org\/10.1530\/EJE-10-1038","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"4484_CR14","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1093\/ejendo\/lvad170","volume":"190","author":"LM Van Zijverden","year":"2024","unstructured":"Van Zijverden LM, Wiepjes CM, Van Diemen JJK, Thijs A, Den Heijer M (2024) Cardiovascular disease in transgender people: a systematic review and meta-analysis. Eur J Endocrinol 190(2):S13-24. https:\/\/doi.org\/10.1093\/ejendo\/lvad170","journal-title":"Eur J Endocrinol"},{"issue":"sup1","key":"4484_CR15","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1080\/26895269.2022.2100644","volume":"23","author":"E Coleman","year":"2022","unstructured":"Coleman E, Radix AE, Bouman WP, Brown GR, De Vries ALC, Deutsch MB et al (2022) Standards of care for the health of transgender and gender diverse people, version 8. Int J Transgend Health 23(sup1):S1-259. https:\/\/doi.org\/10.1080\/26895269.2022.2100644","journal-title":"Int J Transgend Health"},{"key":"4484_CR16","unstructured":"Sex Characteristics - MeSH - NCBI [Internet]. [cited 2026 Apr 25]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/mesh?Cmd=DetailsSearch&Db=mesh&Term=%22Sex+Characteristics%22%5BMeSH+Terms%5D&utm_source=chatgpt.com"},{"key":"4484_CR17","unstructured":"Endocrine Treatment of Gender-Dysphoric\/Gender-Incongruent persons: an endocrine society* clinical practice guideline | The Journal of Clinical Endocrinology and Metabolism | Oxford Academic [Internet]. [cited 2026 Apr 23]. Available from: https:\/\/academic.oup.com\/jcem\/article\/102\/11\/3869\/4157558"},{"key":"4484_CR18","unstructured":"Assessing and Addressing Cardiovascular Health in LGBTQ Adults: a scientific statement from the American Heart Association - PubMed [Internet]. [cited 2026 Mar 30]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33028085\/"},{"issue":"1","key":"4484_CR19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.2307\/2137286","volume":"36","author":"IH Meyer","year":"1995","unstructured":"Meyer IH (1995) Minority stress and mental health in gay men. J Health Soc Behav 36(1):38\u201356","journal-title":"J Health Soc Behav"},{"key":"4484_CR20","unstructured":"Prejudice, Social Stress, and Mental Health in Lesbian, Gay, and Bisexual Populations: Conceptual Issues and Research Evidence - PMC [Internet]. [cited 2026 Mar 30]. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC2072932\/"},{"issue":"5","key":"4484_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11050705","volume":"11","author":"A Hajek","year":"2023","unstructured":"Hajek A, K\u00f6nig HH, Buczak-Stec E, Blessmann M, Grupp K (2023) Prevalence and determinants of depressive and anxiety symptoms among transgender people: results of a survey. Healthcare (Basel) 11(5):705. https:\/\/doi.org\/10.3390\/healthcare11050705","journal-title":"Healthcare (Basel)"},{"key":"4484_CR22","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jad.2020.05.074","volume":"274","author":"M Konrad","year":"2020","unstructured":"Konrad M, Kostev K (2020) Increased prevalence of depression, anxiety, and adjustment and somatoform disorders in transsexual individuals. J Affect Disord 274:482\u2013485. https:\/\/doi.org\/10.1016\/j.jad.2020.05.074","journal-title":"J Affect Disord"},{"key":"4484_CR23","unstructured":"thisisloyal.com L|. More than 40% of transgender adults in the US have attempted suicide. Williams Institute [Internet]. [cited 2026 Mar 30]. Available from: https:\/\/williamsinstitute.law.ucla.edu\/press\/transpop-suicide-press-release\/"},{"issue":"1","key":"4484_CR24","doi-asserted-by":"publisher","first-page":"e2552953","DOI":"10.1001\/jamanetworkopen.2025.52953","volume":"9","author":"C McLellan","year":"2026","unstructured":"McLellan C, Yeh PT, Kennedy CE, Barr\u00e9-Quick M, Rich AJ, Poteat T et al (2026) Global burden of violence against transgender and gender-diverse adults: a systematic review and meta-analysis. JAMA Netw Open 9(1):e2552953. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.52953","journal-title":"JAMA Netw Open"},{"issue":"4","key":"4484_CR25","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.chc.2023.04.001","volume":"32","author":"N Ramos","year":"2023","unstructured":"Ramos N, Marr MC (2023) Traumatic stress and resilience among transgender and gender diverse youth. Child Adolesc Psychiatr Clin N Am 32(4):667\u2013682. https:\/\/doi.org\/10.1016\/j.chc.2023.04.001","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"issue":"8","key":"4484_CR26","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1089\/lgbt.2021.0024","volume":"8","author":"JR Scheer","year":"2021","unstructured":"Scheer JR, Edwards KM, Helminen EC, Watson RJ (2021) Victimization typologies among a large national sample of sexual and gender minority adolescents. LGBT Health 8(8):507\u2013518. https:\/\/doi.org\/10.1089\/lgbt.2021.0024","journal-title":"LGBT Health"},{"key":"4484_CR27","unstructured":"Disparities in School Connectedness, Unstable Housing, Experiences of Violence, Mental Health, and Suicidal Thoughts and Behaviors Among Transgender and Cisgender High School Students \u2014 Youth Risk Behavior Survey, United States, 2023 | MMWR [Internet]. [cited 2026 Mar 30]. Available from: https:\/\/www.cdc.gov\/mmwr\/volumes\/73\/su\/su7304a6.htm"},{"issue":"1","key":"4484_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-023-03195-x","volume":"23","author":"SM Riahi","year":"2023","unstructured":"Riahi SM, Yousefi A, Saeedi F, Martin SS (2023) Associations of emotional social support, depressive symptoms, chronic stress, and anxiety with hard cardiovascular disease events in the United States: the multi-ethnic study of atherosclerosis (MESA). BMC Cardiovasc Disord 23(1):236. https:\/\/doi.org\/10.1186\/s12872-023-03195-x","journal-title":"BMC Cardiovasc Disord"},{"issue":"9438","key":"4484_CR29","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"S Yusuf","year":"2004","unstructured":"Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F et al (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364(9438):937\u2013952. https:\/\/doi.org\/10.1016\/S0140-6736(04)17018-9","journal-title":"Lancet"},{"issue":"4","key":"4484_CR30","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.amepre.2020.03.027","volume":"59","author":"L Kcomt","year":"2020","unstructured":"Kcomt L, Evans-Polce RJ, Veliz PT, Boyd CJ, McCabe SE (2020) Use of cigarettes and e-cigarettes\/vaping among transgender people: results from the 2015 U.S. Transgender Survey. Am J Prev Med 59(4):538\u2013547. https:\/\/doi.org\/10.1016\/j.amepre.2020.03.027","journal-title":"Am J Prev Med"},{"key":"4484_CR31","doi-asserted-by":"publisher","DOI":"10.1177\/1179173X19849419","volume":"12","author":"CW Wheldon","year":"2019","unstructured":"Wheldon CW, Wiseman KP (2019) Tobacco use among transgender and gender non-conforming adults in the United States. Tob Use Insights 12:1179173X19849419. https:\/\/doi.org\/10.1177\/1179173X19849419","journal-title":"Tob Use Insights"},{"issue":"2","key":"4484_CR32","doi-asserted-by":"publisher","first-page":"0297571","DOI":"10.1371\/journal.pone.0297571","volume":"19","author":"JS Lightner","year":"2024","unstructured":"Lightner JS, Schneider J, Grimes A, Wigginton M, Curran L, Gleason T et al (2024) Physical activity among transgender individuals: a systematic review of quantitative and qualitative studies Chan ASW, editor. PLoS ONE 19(2):0297571. https:\/\/doi.org\/10.1371\/journal.pone.0297571","journal-title":"PLoS ONE"},{"key":"4484_CR33","unstructured":"Stress and atherosclerotic cardiovascular disease - PubMed [Internet]. [cited 2026 Mar 30]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/24561512\/"},{"issue":"4","key":"4484_CR34","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/jclp.22880","volume":"76","author":"H Kolp","year":"2020","unstructured":"Kolp H, Wilder S, Andersen C, Johnson E, Horvath S, Gidycz CA et al (2020) Gender minority stress, sleep disturbance, and sexual victimization in transgender and gender nonconforming adults. J Clin Psychol 76(4):688\u2013698. https:\/\/doi.org\/10.1002\/jclp.22880","journal-title":"J Clin Psychol"},{"issue":"5","key":"4484_CR35","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1161\/ATVBAHA.116.307301","volume":"37","author":"AP Arnold","year":"2017","unstructured":"Arnold AP, Cassis LA, Eghbali M, Reue K, Sandberg K (2017) Sex hormones and sex chromosomes cause sex differences in the development of cardiovascular diseases. Arterioscler Thromb Vasc Biol 37(5):746\u2013756. https:\/\/doi.org\/10.1161\/ATVBAHA.116.307301","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"4484_CR36","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/AOG.0b013e31827a08c8","volume":"121","author":"JE Rossouw","year":"2013","unstructured":"Rossouw JE, Manson JE, Kaunitz AM, Anderson GL (2013) Lessons learned from the Women\u2019s Health Initiative trials of menopausal hormone therapy. Obstet Gynecol 121(1):172\u2013176. https:\/\/doi.org\/10.1097\/AOG.0b013e31827a08c8","journal-title":"Obstet Gynecol"},{"key":"4484_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.741866","volume":"12","author":"M Totaro","year":"2021","unstructured":"Totaro M, Palazzi S, Castellini C, Parisi A, D\u2019Amato F, Tienforti D et al (2021) Risk of venous thromboembolism in transgender people undergoing hormone feminizing therapy: a prevalence meta-analysis and meta-regression study. Front Endocrinol 12:741866. https:\/\/doi.org\/10.3389\/fendo.2021.741866","journal-title":"Front Endocrinol"},{"issue":"6","key":"4484_CR38","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.endinu.2018.11.004","volume":"66","author":"G Aranda","year":"2019","unstructured":"Aranda G, Mora M, Hanzu FA, Vera J, Ortega E, Halperin I (2019) Effects of sex steroids on cardiovascular risk profile in transgender men under gender affirming hormone therapy. Endocrinol Diabetes Nutr 66(6):385\u2013392. https:\/\/doi.org\/10.1016\/j.endinu.2018.11.004","journal-title":"Endocrinol Diabetes Nutr"},{"issue":"2","key":"4484_CR39","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jcte.2015.02.003","volume":"2","author":"JD Weinand","year":"2015","unstructured":"Weinand JD, Safer JD (2015) Hormone therapy in transgender adults is safe with provider supervision; a review of hormone therapy sequelae for transgender individuals. J Clin Transl Endocrinol 2(2):55\u201360. https:\/\/doi.org\/10.1016\/j.jcte.2015.02.003","journal-title":"J Clin Transl Endocrinol"},{"issue":"6","key":"4484_CR40","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1161\/HYPERTENSIONAHA.119.13080","volume":"74","author":"PJ Connelly","year":"2019","unstructured":"Connelly PJ, Marie Freel E, Perry C, Ewan J, Touyz RM, Currie G et al (2019) Gender-affirming hormone therapy, vascular health and cardiovascular disease in transgender adults. Hypertension 74(6):1266\u20131274. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.119.13080","journal-title":"Hypertension"},{"key":"4484_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.metop.2022.100173","volume":"13","author":"N Chan Swe","year":"2022","unstructured":"Chan Swe N, Ahmed S, Eid M, Poretsky L, Gianos E, Cusano NE (2022) The effects of gender-affirming hormone therapy on cardiovascular and skeletal health: a literature review. Metab Open 13:100173. https:\/\/doi.org\/10.1016\/j.metop.2022.100173","journal-title":"Metab Open"},{"issue":"1","key":"4484_CR42","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1210\/er.2018-00011","volume":"40","author":"G T\u2019Sjoen","year":"2019","unstructured":"T\u2019Sjoen G, Arcelus J, Gooren L, Klink DT, Tangpricha V (2019) Endocrinology of transgender medicine. Endocr Rev 40(1):97\u2013117. https:\/\/doi.org\/10.1210\/er.2018-00011","journal-title":"Endocr Rev"},{"key":"4484_CR43","unstructured":"Characterising body composition and bone health in transgender individuals receiving gender\u2010affirming hormone therapy - PMC [Internet]. [cited 2026 Apr 11]. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9790536\/#jhn13027-sec-0100"},{"key":"4484_CR44","unstructured":"Changes in regional body fat, lean body mass and body shape in trans persons using cross-sex hormonal therapy: results from a multicenter prospective study - PubMed [Internet]. [cited 2026 Apr 11]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29183889\/"},{"key":"4484_CR45","unstructured":"Body composition following genderaffirming hormone therapy in transgender individuals - PMC [Internet]. [cited 2026 Apr 11]. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12744559\/#abstract1"},{"key":"4484_CR46","doi-asserted-by":"publisher","unstructured":"Body mass index and body composition changes in transgender people undergoing gender-affirming hormone therapy: a systematic review and meta-analysis | Reviews in Endocrine and Metabolic Disorders | Springer Nature Link [Internet]. [cited 2026 Apr 11]. Available from: https:\/\/link.springer.com\/article\/https:\/\/doi.org\/10.1007\/s11154-025-09985-2","DOI":"10.1007\/s11154-025-09985-2"},{"issue":"1","key":"4484_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-024-02131-y","volume":"23","author":"Q Pei","year":"2024","unstructured":"Pei Q, Song Y, Huang Z, Yu H, Xu H, Ye X et al (2024) Effects of gender-affirming hormone therapy on body fat: a retrospective case\u2012control study in Chinese transwomen. Lipids Health Dis 23(1):146. https:\/\/doi.org\/10.1186\/s12944-024-02131-y","journal-title":"Lipids Health Dis"},{"key":"4484_CR48","unstructured":"Skewness in Body fat Distribution Pattern Links to Specific Cardiometabolic Disease Risk Profiles - PubMed [Internet]. [cited 2026 Apr 12]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37795945\/"},{"key":"4484_CR49","unstructured":"Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study - PubMed [Internet]. [cited 2026 Apr 12]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/38350680\/"},{"key":"4484_CR50","unstructured":"Abdominal obesity and metabolic syndrome - PubMed [Internet]. [cited 2026 Apr 12]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/17167477\/"},{"key":"4484_CR51","unstructured":"Cytokines and the immune response in obesity-related disorders - PubMed [Internet]. [cited 2026 Apr 12]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33706888\/"},{"key":"4484_CR52","unstructured":"An Observational Study of Hypertension and Thromboembolism Among Transgender Patients Using Gender-Affirming Hormone Therapy - PMC [Internet]. [cited 2026 Mar 30]. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7173689\/"},{"issue":"3","key":"4484_CR53","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41440-022-01162-1","volume":"46","author":"M Satoh","year":"2023","unstructured":"Satoh M (2023) Blood pressure changes with gender-affirming hormone therapy in transgender people. Hypertens Res 46(3):792\u2013793. https:\/\/doi.org\/10.1038\/s41440-022-01162-1","journal-title":"Hypertens Res"},{"key":"4484_CR54","doi-asserted-by":"publisher","unstructured":"Effects of testosterone therapy on BMI, blood pressure, and laboratory profile of transgender men: a systematic review - Velho - 2017 - Andrology - Wiley Online Library [Internet]. [cited 2026 Mar 31]. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1111\/andr.12382","DOI":"10.1111\/andr.12382"},{"key":"4484_CR55","doi-asserted-by":"publisher","unstructured":"Blood Pressure Effects of Gender-Affirming Hormone Therapy in Transgender and Gender-Diverse Adults | Hypertension [Internet]. [cited 2026 Mar 31]. Available from: https:\/\/www.ahajournals.org\/doi\/https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.120.16839","DOI":"10.1161\/HYPERTENSIONAHA.120.16839"},{"issue":"4","key":"4484_CR56","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1530\/EJE-13-0493","volume":"169","author":"K Wierckx","year":"2013","unstructured":"Wierckx K, Elaut E, Declercq E, Heylens G, De Cuypere G, Taes Y et al (2013) Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case\u2013control study. Eur J Endocrinol 169(4):471\u2013478. https:\/\/doi.org\/10.1530\/EJE-13-0493","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"4484_CR57","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4239\/wjd.v11.i3.66","volume":"11","author":"C Spanos","year":"2020","unstructured":"Spanos C, Bretherton I, Zajac JD, Cheung AS (2020) Effects of gender-affirming hormone therapy on insulin resistance and body composition in transgender individuals: a systematic review. WJD 11(3):66\u201377. https:\/\/doi.org\/10.4239\/wjd.v11.i3.66","journal-title":"WJD"},{"issue":"2","key":"4484_CR58","doi-asserted-by":"publisher","first-page":"411","DOI":"10.2337\/dc19-1061","volume":"43","author":"S Shadid","year":"2020","unstructured":"Shadid S, Abosi-Appeadu K, De Maertelaere AS, Defreyne J, Veldeman L, Holst JJ et al (2020) Effects of gender-affirming hormone therapy on insulin sensitivity and incretin responses in transgender people. Diabetes Care 43(2):411\u2013417. https:\/\/doi.org\/10.2337\/dc19-1061","journal-title":"Diabetes Care"},{"issue":"36","key":"4484_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcte.2024.100349","volume":"30","author":"B Gosiker","year":"2024","unstructured":"Gosiker B, Moutchia J, Nguyen N, Getahun D, Goodman M (2024) Changes in blood lipids following initiation of gender affirming hormone therapy: a systematic review and meta-analysis. J Clin Transl Endocrinol 30(36):100349. https:\/\/doi.org\/10.1016\/j.jcte.2024.100349","journal-title":"J Clin Transl Endocrinol"},{"issue":"10","key":"4484_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2024.101265","volume":"3","author":"SU Rahman","year":"2024","unstructured":"Rahman SU, Manasrah N, Kumar N, Hamza M, Sharma A, Patel N et al (2024) Impact of gender-affirming hormonal therapy on cardiovascular risk factors in transgender health. JACC Adv 3(10):101265. https:\/\/doi.org\/10.1016\/j.jacadv.2024.101265","journal-title":"JACC Adv"},{"issue":"1","key":"4484_CR61","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jacl.2022.11.010","volume":"17","author":"SY Leemaqz","year":"2023","unstructured":"Leemaqz SY, Kyinn M, Banks K, Sarkodie E, Goldstein D, Irwig MS (2023) Lipid profiles and hypertriglyceridemia among transgender and gender diverse adults on gender-affirming hormone therapy. J Clin Lipidol 17(1):103\u2013111. https:\/\/doi.org\/10.1016\/j.jacl.2022.11.010","journal-title":"J Clin Lipidol"},{"key":"4484_CR62","unstructured":"Grant JM, Mottet LA, Tanis J, Harrison J, Herman JL, Keisling M. Injustice at every turn: a report of the National Transgender discrimination SurveySurvey, 2011 [Internet]. [cited 2026 Mar 30]. Available from: https:\/\/transequality.org\/sites\/default\/files\/docs\/resources\/NTDS_Report.pdf"},{"key":"4484_CR63","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1111\/j.1538-7836.2010.03839.x","volume":"5","author":"C Renoux","year":"2010","unstructured":"Renoux C, Dell\u2019ANIELLO S, Suissa S (2010) Hormone replacement therapy and the risk of venous thromboembolism: a population-based study. J Thrombosis Haemostasis 5:979\u2013986. https:\/\/doi.org\/10.1111\/j.1538-7836.2010.03839.x","journal-title":"J Thrombosis Haemostasis"},{"issue":"12","key":"4484_CR64","doi-asserted-by":"publisher","first-page":"4422","DOI":"10.1210\/jc.2012-2030","volume":"97","author":"LJ Seal","year":"2012","unstructured":"Seal LJ, Franklin S, Richards C, Shishkareva A, Sinclaire C, Barrett J (2012) Predictive markers for mammoplasty and a comparison of side effect profiles in transwomen taking various hormonal regimens. J Clin Endocrinol Metab 97(12):4422\u20134428. https:\/\/doi.org\/10.1210\/jc.2012-2030","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"4484_CR65","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.fertnstert.2008.12.017","volume":"93","author":"J Ott","year":"2010","unstructured":"Ott J, Kaufmann U, Bentz EK, Huber JC, Tempfer CB (2010) Incidence of thrombophilia and venous thrombosis in transsexuals under cross-sex hormone therapy. Fertil Steril 93(4):1267\u20131272. https:\/\/doi.org\/10.1016\/j.fertnstert.2008.12.017","journal-title":"Fertil Steril"},{"issue":"2","key":"4484_CR66","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1089\/jwh.2011.2839","volume":"21","author":"MP Goodman","year":"2012","unstructured":"Goodman MP (2012) Are all estrogens created equal? A review of oral vs. transdermal therapy. J Womens Health (Larchmt) 21(2):161\u2013169. https:\/\/doi.org\/10.1089\/jwh.2011.2839","journal-title":"J Womens Health (Larchmt)"},{"issue":"11","key":"4484_CR67","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.1210\/jc.2015-2237","volume":"100","author":"K Mohammed","year":"2015","unstructured":"Mohammed K, Abu Dabrh AM, Benkhadra K, Al Nofal A, Carranza Leon BG, Prokop LJ et al (2015) Oral vs transdermal estrogen therapy and vascular events: a systematic review and meta-analysis. J Clin Endocrinol Metab 100(11):4012\u20134020. https:\/\/doi.org\/10.1210\/jc.2015-2237","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"4484_CR68","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2147\/JBM.S166780","volume":"10","author":"Z Goldstein","year":"2019","unstructured":"Goldstein Z, Khan M, Reisman T, Safer JD (2019) Managing the risk of venous thromboembolism in transgender adults undergoing hormone therapy. J Blood Med 10(10):209\u2013216. https:\/\/doi.org\/10.2147\/JBM.S166780","journal-title":"J Blood Med"},{"key":"4484_CR69","unstructured":"Endocrine Treatment of Gender-Dysphoric\/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline | The Journal of Clinical Endocrinology and Metabolism | Oxford Academic [Internet]. [cited 2026 Apr 13]. Available from: https:\/\/academic.oup.com\/jcem\/article\/102\/11\/3869\/4157558?utm_source=chatgpt.com&login=false"},{"issue":"4","key":"4484_CR70","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/jth.15256","volume":"19","author":"LJJ Scheres","year":"2021","unstructured":"Scheres LJJ, Selier NLD, Nota NM, Van Diemen JJK, Cannegieter SC, Den Heijer M (2021) Effect of gender\u2010affirming hormone use on coagulation profiles in transmen and transwomen. J Thromb Haemost 19(4):1029\u20131037. https:\/\/doi.org\/10.1111\/jth.15256","journal-title":"J Thromb Haemost"},{"issue":"4","key":"4484_CR71","doi-asserted-by":"publisher","first-page":"205","DOI":"10.7326\/M17-2785","volume":"169","author":"D Getahun","year":"2018","unstructured":"Getahun D, Nash R, Flanders WD, Baird TC, Becerra-Culqui TA, Cromwell L et al (2018) Cross-sex hormones and acute cardiovascular events in transgender persons: a cohort study. Ann Intern Med 169(4):205\u2013213. https:\/\/doi.org\/10.7326\/M17-2785","journal-title":"Ann Intern Med"},{"key":"4484_CR72","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1093\/eurheartj\/ehaf837","volume":"47","author":"LM van Zijverden","year":"2025","unstructured":"van Zijverden LM, Thijs A, van Diemen JJK, Wiepjes CM, den Heijer M (2025) Transgender persons receiving gender-affirming hormone therapy: risk of acute cardiovascular events in a Dutch cohort study. Eur Heart J. 47:2660\u20132669. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf837","journal-title":"Eur Heart J."},{"issue":"4","key":"4484_CR73","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1161\/CIRCRESAHA.121.319915","volume":"130","author":"KM Rexrode","year":"2022","unstructured":"Rexrode KM, Madsen TE, Yu AYX, Carcel C, Lichtman JH, Miller EC (2022) The impact of sex and gender on stroke. Circ Res 130(4):512\u2013528. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.319915","journal-title":"Circ Res"},{"key":"4484_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2023.117282","volume":"384","author":"CN Murphy","year":"2023","unstructured":"Murphy CN, Delles C, Davies E, Connelly PJ (2023) Cardiovascular disease in transgender individuals. Atherosclerosis 384:117282. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.117282","journal-title":"Atherosclerosis"},{"key":"4484_CR75","unstructured":"Statin Use in Primary Prevention of Atherosclerotic Cardiovascular Disease According to 5 Major guidelines for sensitivity, specificity, and number needed to treat - PubMed [Internet]. [cited 2026 Apr 5]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31577339\/"},{"key":"4484_CR76","unstructured":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines - PubMed [Internet]. [cited 2026 Apr 5]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/24239921\/"},{"issue":"10","key":"4484_CR77","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1016\/j.jacc.2019.03.010","volume":"74","author":"DK Arnett","year":"2019","unstructured":"Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ et al (2019) 2019 ACC\/AHA guideline on the primary prevention of cardiovasculardisease: a report of the American college of cardiology\/American Heart Association taskforceonclinical practice guidelines. J Am Coll Cardiol 74(10):e177-232. https:\/\/doi.org\/10.1016\/j.jacc.2019.03.010","journal-title":"J Am Coll Cardiol"},{"key":"4484_CR78","unstructured":"SCORE2 and SCORE2-OP calculators [Internet]. [cited 2026 Apr 5]. Available from: https:\/\/www.escardio.org\/guidelines\/practice-tools\/cvd-prevention-toolbox\/score-risk-charts\/"},{"key":"4484_CR79","doi-asserted-by":"crossref","unstructured":"challenge of accurate cardiovascular risk assessment in gender-affirming individuals | European Journal of Preventive Cardiology | Oxford Academic [Internet]. [cited 2026 Apr 5]. Available from: https:\/\/academic.oup.com\/eurjpc\/article\/33\/3\/453\/8104030?login=false","DOI":"10.1093\/eurjpc\/zwaf176"},{"key":"4484_CR80","unstructured":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice - PubMed [Internet]. [cited 2026 Apr 5]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34458905\/"},{"issue":"3","key":"4484_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.focus.2023.100096","volume":"2","author":"TC Poteat","year":"2023","unstructured":"Poteat TC, Rich AJ, Jiang H, Wirtz AL, Radix A, Reisner SL et al (2023) Cardiovascular disease risk estimation for transgender and gender-diverse patients: cross-sectional analysis of baseline data from the LITE plus cohort study. AJPM Focus 2(3):100096. https:\/\/doi.org\/10.1016\/j.focus.2023.100096","journal-title":"AJPM Focus"},{"issue":"1","key":"4484_CR82","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/HPC.0000000000000271","volume":"21","author":"A Malhotra","year":"2022","unstructured":"Malhotra A, Kort S, Lauther T, Mann N, Skopicki HA, Parikh PB (2022) Prevalence and predictors of cardiovascular disease and risk factors in transgender persons in the United States. Crit Pathw Cardiol 21(1):42. https:\/\/doi.org\/10.1097\/HPC.0000000000000271","journal-title":"Crit Pathw Cardiol"},{"key":"4484_CR83","unstructured":"Cross-sex hormones and acute cardiovascular events in transgender persons: a cohort study - PubMed [Internet]. [cited 2026 Apr 13]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29987313\/"},{"key":"4484_CR84","unstructured":"Endocrine Treatment of Gender-Dysphoric\/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline | The Journal of Clinical Endocrinology and Metabolism | Oxford Academic [Internet]. [cited 2026 Apr 13]. Available from: https:\/\/academic.oup.com\/jcem\/article\/102\/11\/3869\/4157558?guestAccessKey="},{"key":"4484_CR85","unstructured":"Venous thromboembolism in transgender and gender non-binary youth is rare and occurs in the setting of secondary risk factors: A retrospective cohort study - PubMed [Internet]. [cited 2026 Apr 13]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39187964\/"},{"issue":"7","key":"4484_CR86","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1111\/j.1538-7836.2008.02981.x","volume":"6","author":"M Righini","year":"2008","unstructured":"Righini M, Perrier A, De Moerloose P, Bounameaux H (2008) D-Dimer for venous thromboembolism diagnosis: 20 years later. J Thromb Haemost 6(7):1059\u20131071. https:\/\/doi.org\/10.1111\/j.1538-7836.2008.02981.x","journal-title":"J Thromb Haemost"},{"issue":"9","key":"4484_CR87","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s11883-022-01047-1","volume":"24","author":"C Ong","year":"2022","unstructured":"Ong C, Liu M, Thermidor S, Eid M, Gianos E (2022) Transgender cardiovascular health: practical management for the clinician. Curr Atheroscler Rep 24(9):721\u2013730. https:\/\/doi.org\/10.1007\/s11883-022-01047-1","journal-title":"Curr Atheroscler Rep"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-026-04484-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-026-04484-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-026-04484-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:53:23Z","timestamp":1787036003000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-026-04484-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":87,"alternative-id":["4484"],"URL":"https:\/\/doi.org\/10.1007\/s11739-026-04484-x","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"assertion":[{"value":"30 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study involved a systematic review of previously published literature and did not involve direct participation of human subjects or animals. Therefore, ethical approval was not required.","order":2,"name":"Ethics","label":"Human and Animal Rights","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was not applicable, as this study did not involve the collection of data from individual human participants.","order":3,"name":"Ethics","label":"Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}